Skip to content
Chair
Chair's Newsroom
About
Internships
Amazon Investigation
Patients, Share Your Story
Ranking Member
Ranking Member's Newsroom
About
Whistleblowers
FAFSA
Hearings
Committee Actions
Legislation
Nominations
About
Members
Subcommittees
Issues
Accessibility
Website Search Open
Submit Site Search Query
Website Search
Home Logo Link
Full Committee Hearing
Why Is Novo Nordisk Charging Americans with Diabetes and Obesity Outrageously High Prices for Ozempic and Wegovy?
Date:
Tuesday, September 24th, 2024
Time:
10:00am
Location:
562 Dirksen Senate Office Building
Open in New Window
Witnesses
Lars Fruergaard Jørgensen
President and Chief Executive Officer
Novo Nordisk
Bagsværd, Denmark
Download Testimony
Related Photos
View null Photo 1
View null Photo 2
View null Photo 3
View null Photo 4
View null Photo 5
View null Photo 6
Chair
Chair's Newsroom
About
Internships
Amazon Investigation
Patients, Share Your Story
Ranking Member
Ranking Member's Newsroom
About
Whistleblowers
FAFSA
Hearings
Committee Actions
Legislation
Nominations
About
Members
Subcommittees
Issues
Accessibility
website-search
Site Search